JCI - Citations to Tumor immunity and autoimmunity induced by immunization with homologous DNA.

Citations to this article

Tumor immunity and autoimmunity induced by immunization with homologous DNA.

L W Weber, … , J J Lewis, A N Houghton

L W Weber, … , J J Lewis, A N Houghton

Published September 15, 1998
Citation Information: J Clin Invest. 1998;102(6):1258-1264. https://doi.org/10.1172/JCI4004.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2022	2021	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1996	Total
Citations:	1	2	1	2	3	4	5	1	2	5	4	11	14	6	7	12	12	12	12	7	16	13	17	11	1	181

Citation information

Citations to this article (181)

Title and authors	Publication	Year
APAVAC Immunotherapy for the Adjuvant Treatment of a Canine Mucosal Melanoma Rinaldi V, Bongiovanni L, Crisi PE, Vignoli M, Peli RE, Masci S, Boari A, Finotello R	Veterinary Sciences	2024
Cancer vaccine strategies using self-replicating RNA viral platforms. Dailey GP, Crosby EJ, Hartman ZC	Cancer Gene Therapy	2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine Gigoux M, Holmström MO, Zappasodi R, Park JJ, Pourpe S, Bozkus CC, Mangarin LM, Redmond D, Verma S, Schad S, George MM, Venkatesh D, Ghosh A, Hoyos D, Molvi Z, Kamaz B, Marneth AE, Duke W, Leventhal MJ, Jan M, Ho VT, Hobbs GS, Knudsen TA, Skov V, Kjær L, Larsen TS, Hansen DL, Lindsley RC, Hasselbalch H, Grauslund JH, Lisle TL, Met Ö, Wilkinson P, Greenbaum B, Sepulveda MA, Chan T, Rampal R, Andersen MH, Abdel-Wahab O, Bhardwaj N, Wolchok JD, Mullally A, Merghoub T	Science Translational Medicine	2022
Spontaneously occurring canine cancer as a relevant animal model for developing novel treatments for human cancers T MIZUNO		2021
Pancreatic Cancer: An Emphasis on Current Perspectives in Immunotherapy K Patel, S Siraj, C Smith, M Nair, JK Vishwanatha, R Basha	Critical Reviews in Oncogenesis	2019
Non-thermal plasma-induced immunogenic cell death in cancer M Khalili, L Daniels, A Lin, FC Krebs, AE Snook, S Bekeschus, WB Bowne, V Miller	Journal of Physics D: Applied Physics	2019
Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis A Thadi, M Khalili, WF Morano, SD Richard, SC Katz, WB Bowne	Human vaccines	2018
Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model J Kraśko, K Žilionytė, A Darinskas, N Dobrovolskienė, A Mlynska, S Riabceva, I Zalutsky, M Derevyanko, V Kulchitsky, O Karaman, N Fedosova, T Symchych, G Didenko, V Chekhun, M Strioga, V Pašukonienė	Oncology Letters	2018
Cutaneous Melanoma C Balch, J Gershenwald, J Thompson, M Atkins, J Kirkwood, R Kefford, A Sober, A Halpern, C Garbe, R Scolyer		2018
Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models WK Decker, RF da Silva, MH Sanabria, LS Angelo, F Guimarães, BM Burt, F Kheradmand, S Paust	Frontiers in immunology	2017
Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial DJ Chung, RD Carvajal, MA Postow, S Sharma, KB Pronschinske, JA Shyer, S Singh-Kandah, MA Dickson, SP D'Angelo, JD Wolchok, JW Young	OncoImmunology	2017
Prostate cancer health disparities: An immuno-biological perspective S Kumar, R Singh, S Malik, U Manne, M Mishra	Cancer Letters	2017
Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma TT Liu, Y Wu, T Niu	Oncotarget	2017
Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines J Menez-Jamet, C Gallou, A Rougeot, K Kosmatopoulos	Annals of translational medicine	2016
A general strategy to optimize immunogenicity of HLA-B0702 restricted cryptic peptides from tumor associated antigens: Design of universal neo-antigen like tumor vaccines for HLA-B0702 positive patients C Gallou, A Rougeot, S Graff-Dubois, K Kosmatopoulos, J Menez-Jamet	Oncotarget	2016
Cancer immunology and canine malignant melanoma: A comparative review MJ Atherton, JS Morris, MR McDermott, BD Lichty	Veterinary Immunology and Immunopathology	2016
Dogs as a Model for Cancer HL Gardner, JM Fenger, CA London	Annual Review of Animal Biosciences	2016
Intraperitoneal immunotherapy: historical perspectives and modern therapy WF Morano, A Aggarwal, P Love, SD Richard, J Esquivel, WB Bowne	Cancer Gene Therapy	2016
Current Protocols in Immunology: Pre-clinical Study of Human Cancer Immunotherapy Z Ya, Y Hailemichael, W Overwijk, NP Restifo	Current Protocols in Immunology: Pre-clinical Study of Human Cancer Immunotherapy	2015
Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use? MM Strioga, A Darinskas, V Pasukoniene, A Mlynska, V Ostapenko, V Schijns	Vaccine	2014
Xenogene vaccination in the therapy of cancer F Cavallo, L Aurisicchio, R Mancini, G Ciliberto	Expert Opinion on Biological Therapy	2014
ENO1-DNA vaccination effectively prolongs survival in a mouse model of human pancreatic cancer Paola Cappello, Simona Rolla, Roberto Chiarle, Anna Novarino, Federica Cavallo, Giovanni Perconti, Mirella Giovarelli, Francesco Novelli	Gastroenterology	2013
Enhanced Responses to Tumor Immunization Following Total Body Irradiation Are Time-Dependent A Diab, RR Jenq, GA Rizzuto, AD Cohen, DW Huggins, T Merghoub, ME Engelhorn, JA Guevara-Patiño, D Suh, VM Hubbard-Lucey, AA Kochman, S Chen, H Zhong, JD Wolchok, MR van Brink, AN Houghton, MA Perales, H Shiku	PloS one	2013
Withrow and MacEwen's Small Animal Clinical Oncology AM Guth, S Dow	Withrow and MacEwen's Small Animal Clinical Oncology	2013
Vaccines against advanced melanoma T Blanchard, PK Srivastava, F Duan	Clinics in Dermatology	2013
Melanoma Immunotherapy: Overcoming Obstacles to Augment Anti-Tumor Immune Responses KM Hargadon	Journal of Cosmetics, Dermatological Sciences and Applications	2013
Biolistic DNA Delivery S Sudowe, AB Reske-Kunz		2012
Biolistic DNA Delivery S Sudowe, AB Reske-Kunz		2012
Biolistic DNA Delivery S Sudowe, AB Reske-Kunz		2012
Biolistic DNA Delivery S Sudowe, AB Reske-Kunz		2012
Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma G Ghanem, J Fabrice	Molecular Oncology	2011
Autoimmunity associated with immunotherapy of cancer SM Amos, CP Duong, JA Westwood, DS Ritchie, RP Junghans, PK Darcy, MH Kershaw	Blood	2011
Advances in Immunology E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné	Advances in Immunology Volume 110	2011
Cancer Vaccines: From Research to Clinical Practice B Jin, AE Yeo	Cancer Vaccines: From Research to Clinical Practice	2011
Combination of epitope-optimized DNA vaccination and passive infusion of monoclonal antibody against HER2/neu leads to breast tumor regression in mice F Orlandi, JA Guevara-Patiño, T Merghoub, JD Wolchok, AN Houghton, PD Gregor	Vaccine	2011
Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma G Ghanem, J Fabrice	Molecular Oncology	2011
Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model WY Yu, TF Chuang, C Guichard, H El-Garch, D Tierny, AT Laio, CS Lin, KH Chiou, CL Tsai, CH Liu, WC Li, L Fischer, RM Chu	Vaccine	2011
Advances in Cancer Research M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken	Advances in Cancer Research Volume 110	2011
Oncolytic plasmid: A novel strategy for tumor immuno-gene therapy C Yoshihara, K Hamada, M Kuroda, Y Koyama	Oncology Letters	2011
Beyond Cancer Vaccines: A Reason for Future Optimism with Immunomodulatory Therapy M Postow, MK Callahan, JD Wolchok	Cancer journal (Sudbury, Mass.)	2011
Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor DA Grosenbaugh, AT Leard, PJ Bergman, MK Klein, K Meleo, S Susaneck, PR Hess, MK Jankowski, PD Jones, NF Leibman, MH Johnson, ID Kurzman, JD Wolchok	American Journal of Veterinary Research	2011
Immunotherapy of Cancer P Yotnda		2010
Immunotherapy of Cancer P Yotnda		2010
Immunotherapy of Cancer P Yotnda		2010
Immunotherapy of Cancer P Yotnda		2010
Immunotherapy of Cancer P Yotnda		2010
Immunotherapy of Cancer P Yotnda		2010
DNA vaccines for the treatment of prostate cancer S Alam, DG McNeel	Expert Review of Vaccines	2010
DNA vaccination: using the patient's immune system to overcome cancer G Eschenburg, A Stermann, R Preissner, HA Meyer, HN Lode	Clinical & developmental immunology	2010
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity F Avogadri, T Merghoub, MF Maughan, D Hirschhorn-Cymerman, J Morris, E Ritter, R Olmsted, AN Houghton, JD Wolchok	PloS one	2010
The hemagglutinin–neuraminidase gene of Newcastle Disease Virus: A powerful molecular adjuvant for DNA anti-tumor vaccination J Ni, V Schirrmacher, P Fournier	Vaccine	2010
Xenogeneic Murine Tyrosinase DNA Vaccine for Malignant Melanoma of the Digit of Dogs CA Manley, NF Leibman, JD Wolchok, IC Rivière, S Bartido, DM Craft, PJ Bergman	Journal of Veterinary Internal Medicine	2010
Immunologic Response to Xenogeneic gp100 DNA in Melanoma Patients: Comparison of Particle-Mediated Epidermal Delivery with Intramuscular Injection BA Ginsberg, HF Gallardo, TS Rasalan, M Adamow, Z Mu, S Tandon, BB Bewkes, RA Roman, PB Chapman, GK Schwartz, RD Carvajal, KS Panageas, SL Terzulli, AN Houghton, JD Yuan, JD Wolchok	Clinical cancer research	2010
Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity F Avogadri, T Merghoub, MF Maughan, D Hirschhorn-Cymerman, J Morris, E Ritter, R Olmsted, AN Houghton, JD Wolchok, D Unutmaz	PloS one	2010
Vitiligo M Picardo, A Taïeb		2010
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response GA Rizzuto, T Merghoub, D Hirschhorn-Cymerman, C Liu, AM Lesokhin, D Sahawneh, H Zhong, KS Panageas, MA Perales, G Altan-Bonnet, JD Wolchok, AN Houghton	Journal of Experimental Medicine	2009
Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments AM Bodles-Brakhop, R Heller, R Draghia-Akli	Molecular Therapy	2009
Immune rejection of mouse tumors expressing mutated self F Duan, Y Lin, C Liu, ME Engelhorn, AD Cohen, M Curran, S Sakaguchi, T Merghoub, S Terzulli, JD Wolchok, AN Houghton	Cancer research	2009
A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo EE Thacker, M Nakayama, BF Smith, RC Bird, Z Muminova, TV Strong, L Timares, N Korokhov, AM O'Neill, TD de Gruijl, JN Glasgow, K Tani, DT Curiel	Vaccine	2009
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma J Yuan, GY Ku, HF Gallardo, F Orlandi, G Manukian, TS Rasalan, Y Xu, H Li, S Vyas, Z Mu, PB Chapman, SE Krown, K Panageas, SL Terzulli, LJ Old, AN Houghton, JD Wolchok	Cancer immunity : a journal of the Academy of Cancer Immunology	2009
Novel strategies for improved cancer vaccines X Chen, CH Chang, DM Goldenberg	Expert Review of Vaccines	2009
Mechanisms of Immunization Against Cancer Using Chimeric Antigens ME Engelhorn, JA Guevara-Patiño, T Merghoub, C Liu, CR Ferrone, GA Rizzuto, DH Cymerman, DN Posnett, AN Houghton, JD Wolchok	Molecular Therapy	2008
Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma YM Saenger, Y Li, KC Chiou, B Chan, G Rizzuto, SL Terzulli, T Merghoub, AN Houghton, JD Wolchok	Cancer research	2008
Dendritic cell based genetic immunization stimulates potent tumor protection dependent on CD8 CTL cells in the absence of autoimmunity S Zhang, W Huang	Journal of Cancer Research and Clinical Oncology	2008
Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer BB Williams, M Wall, RY Miao, B Williams, I Bertoncello, MH Kershaw, T Mantamadiotis, M Haber, MD Norris, A Gautam, PK Darcy, RG Ramsay	Cancer Immunology, Immunotherapy	2008
Generation and characterization of transgenic mice expressing a T-cell receptor specific for the tumour-associated antigen MDM2 SA Xue, GM Bendle, A Holler, HJ Stauss	Immunology	2008
Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma MA Perales, J Yuan, S Powel, HF Gallardo, TS Rasalan, C Gonzalez, G Manukian, J Wang, Y Zhang, PB Chapman, SE Krown, PO Livingston, S Ejadi, KS Panageas, ME Engelhorn, SL Terzulli, AN Houghton, JD Wolchok	Molecular Therapy	2008
Molecular Targeting in Oncology HL Kaufman, S Wadler, K Antman		2008
Shared Immunoproteome for Ovarian Cancer Diagnostics and Immunotherapy: Potential Theranostic Approach to Cancer R Philip, S Murthy, J Krakover, G Sinnathamby, J Zerfass, L Keller, M Philip	Journal of Proteome Research	2007
Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes CS Houghton, ME Engelhorn, C Liu, D Song, P Gregor, PO Livingston, F Orlandi, JD Wolchok, J McCracken, AN Houghton, JA Guevara-Patiño	Vaccine	2007
A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell function GM Bendle, SA Xue, A Holler, HJ Stauss	PloS one	2007
Control of human mesothelin-expressing tumors by DNA vaccines CL Chang, TC Wu, CF Hung	Gene Therapy	2007
The protective effects of in vitro cultivated calculus bovis on the cerebral and myocardial cells in hypoxic mice H Cai, Y Guang, L Liu, P Yao, F Qiu	Journal of Huazhong University of Science and Technology [Medical Sciences]	2007
Safety and Immunogenicity of Tyrosinase DNA Vaccines in Patients with Melanoma JD Wolchok, J Yuan, AN Houghton, HF Gallardo, TS Rasalan, J Wang, Y Zhang, R Ranganathan, PB Chapman, SE Krown, PO Livingston, M Heywood, I Riviere, KS Panageas, SL Terzulli, MA Perales	Molecular Therapy	2007
Construction of porcine CCK pDNA and its expression in COS-7 cells J Bai, Y Lü, Q Bai	Journal of Huazhong University of Science and Technology	2007
Canine Oral Melanoma PJ Bergman	Clinical Techniques in Small Animal Practice	2007
Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag P Felicetti, M Mennecozzi, A Barucca, S Montgomery, F Orlandi, K Manova, AN Houghton, PD Gregor, A Concetti, FM Venanzi	Cytotherapy	2007
A Study of T Cell Tolerance to the Tumor-Associated Antigen MDM2: Cytokines Can Restore Antigen Responsiveness, but Not High Avidity T Cell Function GM Bendle, SA Xue, A Holler, HJ Stauss, J Zimmer	PloS one	2007
A Comparison and Critical Analysis of Preclinical Anticancer Vaccination Strategies JN Kochenderfer, RE Gress	Experimental biology and medicine (Maywood, N.J.)	2007
Construction of porcine CCK pDNA and its expression in COS-7 cells J Bai, Y Lü, Q Bai	Journal of Huazhong University of Science and Technology [Medical Sciences]	2007
Optimization of a self-antigen for presentation of multiple epitopes in cancer immunity José A. Guevara-Patiño, Manuel E. Engelhorn, Mary Jo Turk, Cailian Liu, Fei Duan, Gabrielle Rizzuto, Adam D. Cohen, Taha Merghoub, Jedd D. Wolchok, and Alan N. Houghton	Journal of Clinical Investigation	2006
DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation Miguel-Angel Perales, Adi Diab, Adam D Cohen, Deonka W Huggins, José A Guevara-Patiño, Vanessa M Hubbard, Manuel E Engelhorn, Adam A Kochman, Jeffrey M Eng, Fariborz Mortazavi, Onder Alpdogan, Theis H Terwey, Glenn Heller, Jedd D Wolchok, Alan N Houghton, Marcel R M van den Brink	Journal of immunology (Baltimore, Md. : 1950)	2006
Recombinant Adenovirus Vaccines Can Successfully Elicit CD8+ T Cell Immunity under Conditions of Extreme Leukopenia N Grinshtein, TC Yang, R Parsons, J Millar, G Denisova, D Dissanayake, J Leitch, Y Wan, J Bramson	Molecular Therapy	2006
Translational Medicine JV Tricoli	Prostate Cancer: Translational and Emerging Therapies	2006
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines WW Leitner, ES Bergmann-Leitner, LN Hwang, NP Restifo	Vaccine	2006
Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma JC Liao, P Gregor, JD Wolchok, F Orlandi, D Craft, C Leung, AN Houghton, PJ Bergman	Cancer immunity : a journal of the Academy of Cancer Immunology	2006
Autoimmunity and tumor immunity induced by immune responses to mutations in self ME Engelhorn, JA Guevara-Patiño, G Noffz, AT Hooper, O Lou, JS Gold, BJ Kappel, AN Houghton	Nature Medicine	2006
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center PJ Bergman, MA Camps-Palau, JA McKnight, NF Leibman, DM Craft, C Leung, J Liao, I Riviere, M Sadelain, AE Hohenhaus, P Gregor, AN Houghton, MA Perales, JD Wolchok	Vaccine	2006
Vaccination with liposome–DNA complexes elicits enhanced antitumor immunity L U'Ren, R Kedl, S Dow	Cancer Gene Therapy	2006
DNA Vaccines Against Cancer R Stan, JD Wolchok, AD Cohen	Hematology/Oncology Clinics of North America	2006
Adjuvanticity of Plasmid DNA Encoding Cytokines Fused to Immunoglobulin Fc Domains CR Ferrone, MA Perales, SM Goldberg, CJ Somberg, D Hirschhorn-Cymerman, PD Gregor, MJ Turk, T Ramirez-Montagut, JS Gold, AN Houghton, JD Wolchok	Clinical cancer research	2006
Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8 + T-Cell Responses and Tumor Immunity AD Cohen, A Diab, MA Perales, JD Wolchok, G Rizzuto, T Merghoub, D Huggins, C Liu, MJ Turk, NP Restifo, S Sakaguchi, AN Houghton	Cancer research	2006
A novel DNA vaccine based on ubiquitin-proteasome pathway targeting 'self'-antigens expressed in melanoma/melanocyte M Zhang, C Obata, H Hisaeda, K Ishii, S Murata, T Chiba, K Tanaka, Y Li, M Furue, B Chou, T Imai, X Duan, K Himeno	Gene Therapy	2005
Langerhans Cells Derived from Genetically Modified Human CD34 + Hemopoietic Progenitors Are More Potent Than Peptide-Pulsed Langerhans Cells for Inducing Antigen-Specific CD8 + Cytolytic T Lymphocyte Responses J Yuan, JB Latouche, JL Reagan, G Heller, I Riviere, M Sadelain, JW Young	Journal of immunology (Baltimore, Md. : 1950)	2005
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination PD Gregor, JD Wolchok, V Turaga, JB Latouche, M Sadelain, D Bacich, WD Heston, AN Houghton, HI Scher	International Journal of Cancer	2005
DNA vaccination against tumors GJ Prud'homme	The Journal of Gene Medicine	2005
Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens M Pavlenko, C Leder, P Pisa	Expert Review of Vaccines	2005
Induction of Antigen-Specific Immune Responses Against Malignant Brain Tumors by Intramuscular Injection of Sindbis DNA Encoding Gp100 and IL-18 R Yamanaka, KG Xanthopoulos	DNA and Cell Biology	2005
Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity J Hu, G Li, Y Tong, Y Li, G Zhou, X He, P Xie, JM Wang, Q Sun	International Immunopharmacology	2005
Development of model DNA-vaccine IO Pokholenko, TG Titok, OM Sukhorada, TA Ruban	Biopolymers and Cell	2005
Multiple Administrations of Oligodeoxynucleotides Containing CpG Motifs Influence Ig Isotype Production S Sethi, S Ebner, C Hinske, H Kretzschmar	Immunopharmacology and Immunotoxicology	2005
Cancer Gene Therapy M Yamamoto, DT Curiel	Technology in cancer research & treatment	2005
Tumor Immunology and Cancer Vaccines SN Khleif		2005
Differential Immunogenicity of Two Peptides Isolated by High Molecular Weight-Melanoma-Associated Antigen-Specific Monoclonal Antibodies with Different Affinities W Luo, JC Hsu, CY Tsao, E Ko, X Wang, S Ferrone	Journal of immunology (Baltimore, Md. : 1950)	2005
Immune surveillance in the skin: mechanisms and clinical consequences TS Kupper, RC Fuhlbrigge	Nature Reviews Immunology	2004
Immune recognition of self in immunity against cancer AN Houghton, JA Guevara-Patiño	Journal of Clinical Investigation	2004
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines R Srinivasan, JD Wolchok	Journal of Translational Medicine	2004
Plasmids encoding membrane-bound IL-4 or IL-12 strongly costimulate DNA vaccination against carcinoembryonic antigen (CEA) R Chakrabarti, Y Chang, K Song, GJ Prud’homme	Vaccine	2004
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems PD Gregor, JD Wolchok, CR Ferrone, H Buchinshky, JA Guevara-Patiño, MA Perales, F Mortazavi, D Bacich, W Heston, JB Latouche, M Sadelain, JP Allison, HI Scher, AN Houghton	Vaccine	2004
Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-? ZC Jia, LY Zou, B Ni, Y Wan, W Zhou, YB Lv, M Geng, YZ Wu	Cancer Immunology, Immunotherapy	2004
Immunoendocrinology in Health and Disease N Martens, E Hooghe-Peters, R Hooghe	Immunoendocrinology in Health and Disease	2004
Granulocyte-Macrophage Colony Stimulating Factor: An Adjuvant for Cancer Vaccines DZ Chang, W Lomazow, CJ Somberg, R Stan, MA Perales	Hematology	2004
T-Cell Chauvinists Versus Antibody Advocates—Can't We All Just Get Along? PB Chapman	Journal of Clinical Oncology	2004
Steroidogenic Acute Regulatory (StAR)-Directed Immunotherapy Protects against Tumor Growth of StAR-Expressing Sp2-0 Cells in a Rodent Adrenocortical Carcinoma Model D Ortmann, J Hausmann, F Beuschlein, K Schmenger, M Stahl, M Geissler, M Reincke	Endocrinology	2004
Vaccination-Induced Autoimmune Vitiligo Is a Consequence of Secondary Trauma to the Skin C Lane, J Leitch, X Tan, J Hadjati, JL Bramson, Y Wan	Cancer research	2004
Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-beta. Jia ZC, Zou LY, Ni B, Wan Y, Zhou W, Lv YB, Geng M, Wu YZ	Cancer Immunology, Immunotherapy	2004
Prevention of autoimmune diabetes by DNA vaccination GJ Prud’homme	Expert Review of Vaccines	2003
Cancer Chemotherapy and Biological Response Modifiers Annual MS Turner, JR McKolanis, RK Ramanathan, DC Whitcomb, OJ Finn	Cancer Chemotherapy and Biological Response Modifiers Annual Volume 21	2003
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8 + T Cells WW Overwijk, MR Theoret, SE Finkelstein, DR Surman, LA de Jong, FA Vyth-Dreese, TA Dellemijn, PA Antony, PJ Spiess, DC Palmer, DM Heimann, CA Klebanoff, Z Yu, LN Hwang, L Feigenbaum, AM Kruisbeek, SA Rosenberg, NP Restifo	Journal of Experimental Medicine	2003
Human dendritic cells genetically engineered to express cytosolically retained fragment of prostate-specific membrane antigen prime cytotoxic T-cell responses to multiple epitopes M Mincheff, S Zoubak, I Altankova, S Tchakarov, Y Makogonenko, C Botev, I Ignatova, R Dimitrov, K Madarzhieva, M Hammett, Y Pomakov, H Meryman, T Lissitchkov	Cancer Gene Therapy	2003
Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity T Ramirez-Montagut, MJ Turk, JD Wolchok, JA Guevara-Patino, AN Houghton	Oncogene	2003
CTLA-4 Blockade Enhances the Therapeutic Effect of an Attenuated Poxvirus Vaccine Targeting p53 in an Established Murine Tumor Model J Espenschied, J Lamont, J Longmate, S Pendas, Z Wang, DJ Diamond, JD Ellenhorn	Journal of immunology (Baltimore, Md. : 1950)	2003
A Single Heteroclitic Epitope Determines Cancer Immunity After Xenogeneic DNA Immunization Against a Tumor Differentiation Antigen JS Gold, CR Ferrone, JA Guevara-Patiño, WG Hawkins, R Dyall, ME Engelhorn, JD Wolchok, JJ Lewis, AN Houghton	Journal of immunology (Baltimore, Md. : 1950)	2003
Multiple pathways to tumor immunity and concomitant autoimmunity MJ Turk, JD Wolchok, JA Guevara-Patino, SM Goldberg, AN Houghton	Immunological Reviews	2002
DNA-based immunotherapy: potential for treatment of chronic viral hepatitis? S Beckebaum, VR Cicinnati, G Gerken	Reviews in Medical Virology	2002
Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways WW Leitner, LN Hwang, MJ deVeer, A Zhou, RH Silverman, BR Williams, TW Dubensky, H Ying, NP Restifo	Nature Medicine	2002
Encyclopedia of Cancer G Sgouros	Encyclopedia of Cancer	2002
Tumorimmunabwehr und Autoimmunitat: Erkenntnisse fur die Entwicklung moderner Melanomvakzinen aus tierexperimentellen Studien. Tumor immunity and autoimmunity: lessons for the development of modern melanome vaccines learned in murine models T Tuting, G Reinhard	H&G Zeitschrift fur Hautkrankheiten	2002
Redundant and Alternative Roles for Activating Fc Receptors and Complement in an Antibody-Dependent Model of Autoimmune Vitiligo J Trcka, Y Moroi, RA Clynes, SM Goldberg, A Bergtold, MA Perales, M Ma, CR Ferrone, MC Carroll, JV Ravetch, AN Houghton	Immunity	2002
Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity B Cochlovius, MJ Stassar, MW Schreurs, A Benner, GJ Adema	Immunology Letters	2002
The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen JL Bramson, YH Wan	Expert Opinion on Biological Therapy	2002
Preclinical evaluation of gene transfer products: safety and immunological aspects M Christ	Toxicology	2002
Xenogeneic DNA Immunization in Melanoma Models for Minimal Residual Disease WG Hawkins, JS Gold, NE Blachere, WB Bowne, A Hoos, JJ Lewis, AN Houghton	Journal of Surgical Research	2002
Gene Therapy of Cancer IV Lebedeva, CA Stein	Gene Therapy of Cancer	2002
Strategies to overcome immune ignorance and tolerance MA Perales, NE Blachere, ME Engelhorn, CR Ferrone, JS Gold, PD Gregor, G Noffz, JD Wolchok, AN Houghton	Seminars in Cancer Biology	2002
Melanoma Vaccines MA Perales, JD Wolchok	Cancer Investigation	2002
The Potential of DNA Vaccination against Tumor-Associated Antigens for Antitumor Therapy K Haupt, M Roggendorf, K Mann	Experimental biology and medicine (Maywood, N.J.)	2002
DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice P Hanke, M Serwe, F Dombrowski, T Sauerbruch, WH Caselmann	Cancer Gene Therapy	2002
Melanoma EC Borden	Melanoma	2002
Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy L Fong, D Brockstedt, C Benike, JK Breen, G Strang, CL Ruegg, EG Engleman	Journal of immunology (Baltimore, Md. : 1950)	2001
Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen YQ Wei, MJ Huang, L Yang, X Zhao, L Tian, Y Lu, JM Shu, CJ Lu, T Niu, B Kang, YQ Mao, F Liu, YJ Wen, S Lei, F Luo, LQ Zhou, F Peng, Y Jiang, JY Liu, H Zhou, QR Wang, QM He, F Xiao, YY Lou, XJ Xie, Q Li, Y Wu, ZY Ding, B Hu, M Hu, W Zhang	Proceedings of the National Academy of Sciences	2001
B16 as a mouse model for human melanoma WW Overwijk, NP Restifo	Current protocols in immunology / edited by John E. Coligan ... [et al.]	2001
MHC Class II–Restricted Tumor Antigens Recognized by CD4+ T Cells: New Strategies for Cancer Vaccine Design G Zeng	Journal of Immunotherapy	2001
Immunity against cancer: lessons learned from melanoma AN Houghton, JS Gold, NE Blachere	Current Opinion in Immunology	2001
Vaccines for melanoma: translating basic immunology into new therapies JD Wolchok, PO Livingston	The Lancet Oncology	2001
Metastatic lesions in the joint associated with acute inflammatory arthritis after dendritic cell immunotherapy for metastatic melanoma R Thomas, J Padmanabha, M Chambers, S McFadyen, E Walpole, G Nielssen, M Smithers	Melanoma Research	2001
Autoimmune Aspects of Vitiligo EH Kemp, EA Waterman, AP Weetman	Autoimmunity	2001
Autoimmune Melanocyte Destruction in Vitiligo R Wijngaard, A Wankowicz-Kalinska, S Pals, J Weening, P Das	Laboratory Investigation	2001
Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4+ T cell-dependent mechanism J Steitz, J Brück, J Knop, T Tüting	Gene Therapy	2001
The Skin and Gene Therapy UR Hengge, B Volc-Platzer		2001
Induction of a Cellular and Humoral Immune Response against Preprocalcitonin by Genetic Immunization: A Potential New Treatment for Medullary Thyroid Carcinoma* K Haupt, F Siegel, M Lu, D Yang, G Hilken, K Mann, M Roggendorf, B Saller	Endocrinology	2001
Renal Cancer: Methods and Protocols JH Mydlo		2001
Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease K Yamaki, K Gocho, K Hayakawa, I Kondo, S Sakuragi	Journal of immunology (Baltimore, Md. : 1950)	2000
Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other" WW Overwijk, NP Restifo	Critical reviews in immunology	2000
Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease B Ludewig, AF Ochsenbein, B Odermatt, D Paulin, H Hengartner, RM Zinkernagel	Journal of Experimental Medicine	2000
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo V Bronte, E Apolloni, R Ronca, P Zamboni, WW Overwijk, DR Surman, NP Restifo, P Zanovello	Cancer research	2000
Amplification of T Cell-Mediated Immune Responses by Antibody-Cytokine Fusion Proteins HN Lode, R Xiang, SD Gillies, RA Reisfeld	Immunological Investigations	2000
Costimulatory wars: the tumor menace AA Hurwitz, ED Kwon, A Elsas	Current Opinion in Immunology	2000
Immunization with DNA coding for gp100 results in CD4+ T-cell independent antitumor immunity WG Hawkins, JS Gold, R Dyall, JD Wolchok, A Hoos, WB Bowne, R Srinivasan, AN Houghton, JJ Lewis	Surgery	2000
Genetic immunization of mice with human tyrosinase-related protein 2: Implications for the immunotherapy of melanoma J Steitz, J Br�ck, K Steinbrink, A Enk, J Knop, T T�ting	International Journal of Cancer	2000
Intracutaneous Genetic Immunization with Autologous Melanoma-Associated Antigen Pmel17/gp100 Induces T Cell-Mediated Tumor Protection In Vivo SN Wagner, C Wagner, P Luhrs, TK Weimann, R Kutil, M Goos, G Stingl, A Schneeberger	Journal of Investigative Dermatology	2000
Immunization of ovarian cancer patients with a synthetic Lewisy-protein conjugate vaccine: A phase 1 trial PJ Sabbatini, V Kudryashov, G Ragupathi, SJ Danishefsky, PO Livingston, W Bornmann, M Spassova, A Zatorski, D Spriggs, C Aghajanian, S Soignet, M Peyton, C O'Flaherty, J Curtin, KO Lloyd	International Journal of Cancer	2000
Immunotherapy with Dendritic Cells Directed against Tumor Antigens Shared with Normal Host Cells Results in Severe Autoimmune Disease B Ludewig, AF Ochsenbein, B Odermatt, D Paulin, H Hengartner, RM Zinkernagel	Journal of Experimental Medicine	2000
Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice CF Grimm, D Ortmann, L Mohr, S Michalak, TU Krohne, S Meckel, S Eisele, J Encke, HE Blum, M Geissler	Gastroenterology	2000
Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide JJ Lewis, S Janetzki, S Schaed, KS Panageas, S Wang, L Williams, M Meyers, L Butterworth, PO Livingston, PB Chapman, AN Houghton	International Journal of Cancer	2000
IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice K Song, Y Chang, GJ Prud'homme	Gene Therapy	2000
Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy M Brenner, C Rossig, U Sili, JW Young, E Goulmy	Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program	2000
Identification of CD4 + T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules G Zeng, CE Touloukian, X Wang, NP Restifo, SA Rosenberg, RF Wang	Journal of immunology (Baltimore, Md. : 1950)	2000
Divergent Roles for CD4 + T Cells in the Priming and Effector/Memory Phases of Adoptive Immunotherapy HM Hu, H Winter, WJ Urba, BA Fox	Journal of immunology (Baltimore, Md. : 1950)	2000
Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12 HN Lode, R Xiang, SR Duncan, AN Theofilopoulos, SD Gillies, RA Reisfeld	Proceedings of the National Academy of Sciences	1999
Coupling and uncoupling of tumor immunity and autoimmunity WB Bowne, R Srinivasan, JD Wolchok, WG Hawkins, NE Blachere, R Dyall, JJ Lewis, AN Houghton	Journal of Experimental Medicine	1999
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation A Elsas, AA Hurwitz, JP Allison	Journal of Experimental Medicine	1999
Human tumor antigens for cancer vaccine development RF Wang, SA Rosenberg	Immunological Reviews	1999
Autoaggression and tumor rejection: it takes more than self-specific T-cell activation R Ganss, A Limmer, T Sacher, B Arnold, GJ Hammerling	Immunological Reviews	1999
Interpreting cancer vaccine clinical trials G Dranoff	The Journal of Gene Medicine	1999
DNA vaccines for cancer therapy HM Horton, SE Parker, MK Wloch, JA Norman	Expert Opinion on Investigational Drugs	1999
Coupling and Uncoupling of Tumor Immunity and Autoimmunity WB Bowne, R Srinivasan, JD Wolchok, WG Hawkins, NE Blachere, R Dyall, JJ Lewis, AN Houghton	Journal of Experimental Medicine	1999
Combination Immunotherapy of B16 Melanoma Using Anti-Cytotoxic T Lymphocyte-Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation A Elsas, AA Hurwitz, JP Allison	Journal of Experimental Medicine	1999
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy WW Overwijk, DS Lee, DR Surman, KR Irvine, CE Touloukian, CC Chan, MW Carroll, B Moss, SA Rosenberg, NP Restifo	Journal of immunology (Baltimore, Md. : 1950)	1999
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Overwijk WW, Lee DS, Surman DR, Irvine KR, Touloukian CE, Chan CC, Carroll MW, Moss B, Rosenberg SA, Restifo NP	Proceedings of the National Academy of Sciences	1999
DNA vaccines JB Ulmer, JC Sadoff, MA Liu	Current Opinion in Immunology	1996

Advertisement